News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

Sea Ltd.'s Q4 Earnings Miss Shadows Massive 38% Revenue Surge For Shopee, Garena
Finviz·2026/03/03 17:36
Cardano Jumps, USDCX Becomes Top Stablecoin As Midnight Nears Mainnet
DailyCoin·2026/03/03 17:36
AVAX Tests $9.38 Resistance After 8.3% Surge — Breakout or Pullback Ahead?
Cryptonewsland·2026/03/03 17:33
Ziff Davis Stock Explodes On $1.2 Billion Accenture Connectivity Deal
Finviz·2026/03/03 17:33
US considering oil tanker insurance support to ease Middle East crude shipments, sources say
101 finance·2026/03/03 17:30
Global imbalances: significance and a ‘non-event’
101 finance·2026/03/03 17:30

Ethereum price outlook as exchange withdrawals hit highest level since November — will $2K support hold?
Crypto.News·2026/03/03 17:27
Vale Base Metals aims to be IPO-ready by midyear, CEO says
Mining.com·2026/03/03 17:27

Trump Escalates Pressure on Iran as Trade Tensions with Spain and UK Heat Up
Cointurk·2026/03/03 17:24
Can Ralph Lauren's Store Expansion Boost Brand Value & Sales?
Finviz·2026/03/03 17:21
Flash
12:30
Analysis: BTC and the US dollar strengthen simultaneously, attracting market attention; the key resistance level in the near term may be at $74,000ChainCatcher news, according to market sources, bitcoin is currently approaching the key resistance level of $74,000, with a cumulative increase of over 10% since the outbreak of the Middle East conflict. Notably, this round of gains has occurred against the backdrop of declining risk appetite in global stock markets and a strengthening US dollar. The US Dollar Index (DXY) has risen by more than 1% this week, reaching 99.68 on Wednesday, its highest level since November last year. Historically, bitcoin has usually shown a negative correlation with the US dollar, but since Trump won the 2024 presidential election and proposed pro-crypto policies, the two have often moved in tandem.
12:26
Biopharmaceutical company Erasca, Inc. (NASDAQ: ERAS) and Tango Therapeutics Inc. (NASDAQ: TNGX) announced a clinical collaboration to jointly conduct clinical evaluation of the combination therapy of ERAS-0015 and vopimetostat.This collaboration aims to explore the potential of combining two innovative therapies, providing patients with more effective treatment options. Both parties plan to validate the synergistic effects of the combined approach through clinical research, with a focus on its safety and efficacy in specific indications. This partnership marks an important step forward for both companies in the field of tumor treatment and is expected to accelerate the development process of innovative therapies.
12:26
JD.com management disclosed during a conference call that the number of active customers in the fourth quarter achieved a significant year-on-year growth of 30%.This strong growth is mainly attributed to the organic expansion of users in the core retail business, as well as the positive contributions from emerging business initiatives such as JD Takeaway.